Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356843 · ClinicalTrials.gov registry record
Palliative Care for People With HF
A clinical trial of Congestive Heart Failure and Congestive Heart Failure(CHF), sponsored by Indiana University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07356843 is a study of Congestive Heart Failure and Congestive Heart Failure(CHF) that is actively recruiting participants, run by Indiana University. The registered enrollment target is 20 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07356843, a study of Congestive Heart Failure and Congestive Heart Failure(CHF), is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Imagine having heart failure, a condition where the heart struggles to pump blood, making daily life hard. People with heart failure often don't feel well and end up going to the hospital a lot. Many of these people could feel better with extra help, but there aren't many programs that offer support beyond usual heart failure treatments. That's where the ADAPT program comes in, which stands for "Advancing Symptom Alleviation with Palliative Treatment." In this program, nurses and social workers call people weekly, helping them manage their toughest symptoms, offering tools to cope with heart failure, and keeping the patients' current doctors involved. We tested this program in a research study with heart failure patients and found that it improved their quality of life and lowered depression, anxiety, and heart failure symptoms. We now want to see if the ADAPT program will work in the community, outside of a research setting, so that more people could benefit from it. Specifically, we want to know: can the ADAPT program work well in new places? Will patients and their families find it helpful? Most importantly, can it help improve the lives of people with heart failure in these new settings? To answer these questions, I'll team up with healthcare providers to 1) ask how we can adjust the ADAPT program to work well in various settings (e.g. primary care, heart failure clinic) and 2) use this information to create simple materials and trainings to help them easily provide ADAPT. This will prepare us for the next phase of this project to test out the new ADAPT program.
Conditions Studied
Interventions
- OTHER ADAPT
Study Locations (1)
Indiana
- IUHealth - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-10-20 |
| Est. Completion | 2028-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07356843
The ClinicalTrials.gov registry entry for NCT07356843 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (94% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which ADAPT is the first listed.
NCT07356843 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT07356843 about?
NCT07356843 is a clinical study titled "Palliative Care for People With HF". Imagine having heart failure, a condition where the heart struggles to pump blood, making daily life hard. People with heart failure often don't feel well and end up going to the hospital a lot. Many of these people could feel better with extra help, but there aren't many programs that offer support...
What is the current status of trial NCT07356843?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-10-20. Estimated completion is 2028-09.
What conditions does trial NCT07356843 study?
This clinical trial studies the following conditions: Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure Chronic, Congestive Heart Failure (CHF).
What interventions are being tested in trial NCT07356843?
The interventions under investigation include: ADAPT (OTHER).
Who is sponsoring clinical trial NCT07356843?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07356843 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
RECRUITING · Phase 1
-
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.